Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.
NCT00043212 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2013-05-01
Summary
The purpose of this clinical research study is to assess the safety and efficacy of an investigational therapy called DCVax(TM)-Prostate.
Conditions
Interventions
- DRUG
-
Dendritic cell immunotherapy
Sponsors & Collaborators
-
Northwest Biotherapeutics
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate
NCT00001382 ·Status: COMPLETED ·Phase: PHASE1
-
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
NCT06966024 ·Status: RECRUITING ·Phase: PHASE1
-
Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT01145508 ·Status: TERMINATED ·Phase: PHASE2
-
Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy
NCT02153918 ·Status: COMPLETED ·Phase: PHASE2
-
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance
NCT02326805 ·Status: COMPLETED ·Phase: PHASE2
-
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
NCT00089856 ·Status: TERMINATED ·Phase: PHASE3
-
Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
NCT00133224 ·Status: TERMINATED ·Phase: PHASE3
-
Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00110214 ·Status: COMPLETED ·Phase: PHASE3
-
Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer
NCT00849121 ·Status: COMPLETED ·Phase: PHASE2
-
DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
NCT00024414 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
NCT02111577 ·Status: COMPLETED ·Phase: PHASE3
-
Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies
NCT02985021 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer
NCT03514836 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer
NCT02107430 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00005096 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer Patients
NCT00714376 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer
NCT00521274 ·Status: TERMINATED ·Phase: PHASE2
-
PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer
NCT02933255 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer
NCT02137746 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy in Treating Patients With Prostate Cancer
NCT00004045 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
NCT01322490 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
NCT01540071 ·Status: COMPLETED ·Phase: PHASE2
-
Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00010231 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer
NCT00583024 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21
NCT00583752 ·Status: COMPLETED ·Phase: PHASE2